The Joint Corp. (JYNT)

CIK 0001612630 · Healthcare · Medical Care Facilities

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-06) · 99.1 · 99.2
Q1-2026 8-K (2026-05-07) · 99.1 · 99.2
Latest FY-2025 8-K (2026-03-12) · 99.1 · 99.2
Q3-2025 8-K (2025-11-06) · 99.1 · 99.2 · 99.3
Q1-2025
Q2-2025 8-K (2025-08-07) · 99.1 · 99.2  |  8-K (2025-07-30) · 99.1
FY-2024
Q1-2025 8-K (2025-05-08) · 99.1 · 99.2
FY-2024 8-K (2025-03-13) · 99.1 · 99.2  |  8-K (2025-01-16) · 99.1
Q3-2024 8-K (2024-11-07) · 99.1 · 99.2
Q2-2024 8-K (2024-08-08) · 99.1 · 99.2
Q1-2024 8-K (2024-05-02) · 99.1 · 99.2
FY-2023 8-K (2024-03-07) · 99.1 · 99.2
Q3-2023 8-K (2023-11-09) · 99.1 · 99.2
Q1-2023
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Operations
—
Consolidated Income Statements
Consolidated Statements of Changes In Stockholders' Equity
Consolidated Statements of Cash Flows
Notes
Acquisitions and Assets Held For Sale
Acquisitions and Divestitures
—
Assets Held For Sale
—
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Divestitures
Employee Retention Credit
Fair Value Consideration
—
Fair Value Measurements
—
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangible Assets
—
Intangible Assets and Goodwill
—
Nature of Operations and Summary of Significant Accounting Policies
Pay Vs Performance Disclosure
Property and Equipment
Quarterly Financial Data (unaudited)
—
Related ?party? Transaction
Related Party Transactions
—
Related €‹party​ Transactions
—
Revenue Disclosures
Segment Reporting
Stock-based Compensation
Stockholders' Equity
Subsequent Events
Supplemental Cash Flow Disclosures